Lexicon Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Lexicon Pharmaceuticals using advanced sorting and filters.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-06 | $-0.04 | $-0.07 | 42.9 % |
| Q2 | 2025-08-06 | $0.01 | $-0.08 | 112.5 % |
| Q1 | 2025-05-13 | $-0.07 | $-0.10 | 30.0 % |
| Q4 | 2025-03-06 | $-0.09 | $-0.12 | 25.0 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-06 | $14.18M | $5.15M | 175.6 % |
| Q2 | 2025-08-06 | $28.87M | $5.52M | 423.3 % |
| Q1 | 2025-05-13 | $1.26M | $2.12M | -40.5 % |
| Q4 | 2025-03-06 | $26.55M | $6.48M | 309.8 % |
Lexicon Pharmaceuticals (LXRX) is scheduled to report earnings on March 5, 2026. The last reported earnings were for reported on November 6, 2025 for Q3.
The Actual EPS was $-0.04, which beat the estimate of $-0.07.
The Actual Revenue was $14.2M, which beat the estimate of $5.1M.
Browse earnings estimates, EPS, and revenue on all stocks.